Stay updated on Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial
Sign up to get notified when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.

Latest updates to the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoval of the government funding/operating status banner from the page; study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe new screenshots show only minor UI adjustments and formatting changes with no updates to study details, eligibility criteria, outcomes, or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0). The core impact is informing users about potential delays and where to check status.SummaryDifference2%

- Check78 days agoChange DetectedAdded a new version label (v3.1.0) and removed several drug-safety topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older version tag (v3.0.2); overall, content scope is being simplified/reorganized with emphasis on versioning.SummaryDifference0.2%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.